A small-scale bioreactor that you can setup in 10 minutes!
For whitepapers and more info, visit www.atSpiro.com or send us a mail on hi@atspiro.com
A small-scale bioreactor that you can setup in 10 minutes!
For whitepapers and more info, visit www.atSpiro.com or send us a mail on hi@atspiro.com
The MarketsandMarkets Next-Gen Immuno Oncology Conference is an upcoming event scheduled to take place on 5th-6th October 2023 in Frankfurt, Germany. This conference aims to bring together experts, researchers, and industry leaders from the field of immuno-oncology to discuss the latest advancements and innovations in the field. With the increasing importance of immunotherapy in cancer treatment, this conference serves as a platform for knowledge exchange and collaboration among professionals working in the field.
Conference Registration: https://events.marketsandmarkets.com/immuno-oncology-conference-germany/register
During the two-day conference, attendees will have the opportunity to gain insights from keynote presentations, panel discussions, and interactive sessions led by renowned experts in immuno-oncology. The conference will cover a wide range of topics including novel immunotherapeutic approaches, cutting-edge technologies, clinical trials, and personalized medicine. Participants will also get a chance to explore emerging trends, network with peers, and engage in discussions that will shape the future of immuno-oncology. The MarketsandMarkets Next-Gen Immuno Oncology Conference promises to be an informative and impactful event for anyone involved in the field of immuno-oncology, providing a platform for knowledge sharing and fostering collaborations to advance cancer treatment.
The 6th Annual MarketsandMarkets Neuroscience R&D Conference is a highly anticipated event for scientists, researchers, and business leaders working in the field of neuroscience. The conference is scheduled to take place on 9th - 10th October 2023 in London and will focus on emerging trends, challenges, and innovations in neuroscience research and development. The conference will bring together some of the most renowned experts in the field of neuroscience to discuss the latest advancements in the field and share insights on how to leverage these advancements to improve human health.
One of the key benefits of attending the MarketsandMarkets Neuroscience R&D Conference is the opportunity to network with like-minded professionals. Participants will have the chance to meet and interact with experts in the field, share ideas, and learn about the latest trends and innovations in neuroscience. Additionally, the conference will offer attendees the opportunity to participate in interactive sessions, panel discussions, and case studies, providing a valuable learning experience. Finally, sponsors of the conference will have the opportunity to showcase their products and services to a targeted audience, positioning their brand as a leader in the field of neuroscience research and development. Explore the event and register today.
RWDA, Germany:
The healthcare sector, which has relied on diverse clinical trials, medical literature, patient outcomes data, case studies, or treatment patterns, has struggled for decades to efficiently integrate and analyze this data consistently. With the recent data boom the sector is experiencing, this dilemma is getting more urgent. Real-world data (RWD), which focuses on the needs of the patient, is becoming more and more important in guiding medical policy. The monitoring of post-marketing medication safety and decision assistance in clinical practice are just two processes that RWD influences and informs. If analytics, machine learning, and artificial intelligence are used to fuel RWD, it will eventually transform into actionable real-world evidence (RWE), which could finally result in the right medicine being administered at the appropriate moment.
Here is a great opportunity for you to witness and network with real-world evidence and Life Sciences Analytics' latest innovations and research studies. Join us at our 6th Annual Markets and Markets Real-World Evidence and Life Sciences Analytics Conference, scheduled to be held on October 5–6, 2023, in Frankfurt, Germany. The major takeaway from this conference will be improved decision-making. It will be centered on the important aspects mentioned above and hold discussions on the best practices followed by various stakeholders. Register Now
Passed ISO9001 quality certification system!
Hi Rudolf, I am new here too. Can we be accountability partners so I am not nervous walking alone?
Good morning All! I am new to PharmeMed. Very excited to be here, to learn, and hopefully get to know some of you.
Technology advancement for the 21st centuryTechnology advancement for the 21st century
Joshua Yang, Co-founder & CEO of Glyphic Biotechnologies and Co-founder of NephroSant, sat down with me to explore the applications of next-generation protein sequencing for biomedical research and clinical medicine, his journey from academia to entrepreneurship, and much more.
Notice me
Good morning sir.
Performs GMP Safety and Environmental regulatory tasks required in the manufacturing area.
v Handling of chemical and biological spillages, and handles Hazardous and Non-hazardous waste according to EHS procedures.
I'm looking to speak with Bio-pharma process specialists with SIP / CIP experience urgently. If you're interested in a new role in Switzerland I welcome your contact.
Dear all,
As you all must be aware, there are lot of digital leaders and research organisations focusing on biomarker research to understand the nature of ebiomarkers and how it could lead to better diagnostic tool(s) for the future patients.
I thought I would reach out to a wider network if any of you is interested to purchase the domain I own. The name of the domain is https://eBiomarkers.com/ and in brief it simply represents Digital Biomarkers.
I strongly believe that this domain has strong potential in biomarker research and in digital health as a whole. I believe the domain could act as a library of every eBiomarker ever discovered, researched and implemented in everyday life. A platform which will allow researchers and public members to learn on biomarkers, their relevant recent activities, their significance and much more which could be accessible globally.
I would be really obliged to hear your thoughts. Please do visit the page and any feedback is welcome. Many thanks for your time in reading this. I really look forward to hearing from you (maybe with an offer!?).
Best wishes,
Bhavesh Pratap
Domain owner of eBiomarkers.com
My UK number is +44-77-33-640-321
https://eBiomarkers.com/
https://dan.com/buy-domain/eBiomarkers.com
I am available for work assistance
Jobs
I am a Versatile Ph.D.
Polymer/Organic Chemist and Inventor with 10 + years of international
experience. Proficient in synthesis, characterization, product and process
development, prototyping, development and commercialization of transformative
biomedical technologies to improve the safety and effectiveness of medical
devices.
I worked on patented
technologies for saving lives, currently in medical devices approved world-wide
and also in US clinical trials. These involve technologies to reduce thrombus
in medical devices without the use of Heparin and impart antimicrobial
properties for infection control without the use of antibiotics. I have 25
patents till date on these.
I am looking for new
opportunities in the Polymer/Organic Chemistry Applications with a focus on
Biotechnology including Biomedical Polymers, Medical devices, Polymer
Therapeutics, Regenerative Medicine, Tissue Engineering &
Bio-Pharmaceuticals and also for Industrial Applications e.g Construction materials, foams, sealants,
adhesives, insulations, electronics etc. I
have a unique complementary skill-set that can be transferred to a variety of
employment areas. I have attached my CV for your review should there be any
positions as a Polymer/Materials Chemist. Look forward to your feedback.
Sincerely,
Sanjoy Mullick, Ph.D
Dear Pharmemed Members,
In order to obtain my Advanced Master degree in Biotechnology & Pharmaceutical Management (at Grenoble Business School), I invite you to participate in this survey which will be included in my professional Thesis :
https://fr.surveymonkey.com/r/CI_Collaborative_Practices
I would be really grateful for your help.
Only 5 minutes are needed to complete it and it’s completely anonymous.
My Thesis aims to describe current Competitive Intelligence practices in terms of internal collaboration, in the Health Industry (Pharmaceutical, Biotech, IVD, or Medical Devices companies). The goal is to identify what enhances or limits this collaboration.
Please do not hesitate to contact me if you have any questions or if you want me to share with you the results of this survey. Thank you very much in advance for your participation.
Best regards,
Terence Villa
terence.villa@grenoble-em.com
https://fr.linkedin.com/in/terence-villa-biology
Try to find job Try to find job Try to find job Try to find job
My client is searching for a STRONG Pharmaceutical/Biotech Sales Representative with a documented track record of success:
- The company is a leader in the Pharma, Biotech, Medical industry
- Territory encompasses the GREATER NORTHERN VA | D.C. | BALTIMORE AREA
- Call points include Immunologists, Allergists & other Specialty Physicians
- Competitive Base Salary $125-150K (commensurate with exp.) Bonus At Plan $48K,
- Full Benefits, Company Vehicle, 401K, All Business Expenses, Vacation, etc…
- Ideal candidate has Specialty Pharmacy, Immunology Experience
- RARE DISEASE EXPERIENCE IS REQUIRED
If you’re interested in learning more please shoot over an updated resume to bwiley@cartermackay.com and we can discuss this opportunity further.
My client, a revolutionary #biotechnology company who is dedicated to improving cancer outcomes is seeking a Computational Biologist! This exciting role offers competitive pay, great benefits & a quirky, casual yet very focused work environment. You can expect to be developing algorithms for detection of cancer mutations, as well as analyzing present data from clinical trials, academic collaborations, and FDA validation studies. If you, or someone in your network would be interested in hearing more, please reach out! ***Relocation available***
Achieving commercial success for an IVD product or an LDT assay is becoming progressively more difficult in the current healthcare environment. The combination of tightening budgets and the launch of a large number of expensive molecular tests creates complications for payers to respond in traditional ways. Cambridge Healthtech Institute’s 2nd Annual Dx Reimbursement Outlook symposium will provide its participants with a unique opportunity to discuss winning strategies with government and private payers as well as with their peers who are working on similar tasks.
https://www.triconference.com/Dx-Reimbursement-Outlook
Good Morning Jim - what if we wanted an opinion (as a recruiter) on the best way to speak with people inside the pharmaceutical sector - would you be happy to answer questions on that front?
Kind regards,
Luke Blaney
If you are looking for another perspective on something that you are currently working on, or would like an opportunity to discuss current healthcare/pharma/biotech in 2017, please don't hesitate to reach out to me directly.Jim